Clinical Trial Update: Screening Epidemiological Program on Compensation Evaluation of Diabetes Mellitus Type 2 (DMT2) Patients on Oral Anti-diabetic (OAD) Monotherapy and Physicians Satisfaction of Their Usage

View source ↗

Summary

A completed clinical trial update evaluating compensation strategies for patients with Type 2 diabetes mellitus on oral antidiabetic monotherapy and measuring p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Status: COMPLETED